Clinical Trials

Beaumont Health is committed to creating an ideal environment for the conduct of exemplary clinical research by providing only the best investigational treatment options for our patients.


With eight hospitals serving southern Michigan and beyond, Beaumont is a highly productive contributor to clinical trials across the nation. The Beaumont Research Institute strengthens Beaumont's ability to conduct medical research and to provide a research training experience for the medical staff and participants in graduate medical education programs.

Search Clinical Trials

Clinical Trial Resources

For more information about research and clinical trials, you can visit the following government and private sites:

  • ClinicalTrials.gov: This site maintained by the National Library of Medicine provides extensive clinical trials information including a database of active clinical trials in the U.S.
  • FDA: U.S. Food and Drug Administration: This site provides education for CONSUMERS about clinical research
  • Journal of the American Medical Association: (PDF) This patient page from the respected journal provides a summary of clinical trials from the standpoint of the volunteer participant
  • Office of Human Research Protection: This patient page, About Research Participation, provides the public with information about research and research participation, so potential volunteer can make informed decisions about participating in research
  • U.S. National Institutes of Health Clinical Trials: This site provides National Institute of Health resources for patients and families, including an extensive glossary of terminology used in clinical research

 

Questions about clinical trials at Beaumont? Call

248-551-7835

ATTENTION BEAUMONT HEALTH EMPLOYEES

All Beaumont team members who would like to volunteer for the BLAST COVID-19 serological testing study will receive a personal invitation in their Beaumont email with the direct link to learn more about the project, provide consent and schedule a blood draw. Due to the logistical challenges involved in testing over 30,000 people twice, Research Institute is rolling the study out using this phased approach. Please watch your email over the next week or two for an invitation to register. Priority will be given to employees treating COVID-19 patients.